11，Maslak PG,Weiss MA,Berman E,et al.Granulocytecolony-stimulating factor following chemotherapy in elderly patients with newly diagnosedacute myelogenous leukemia.Leukemia,1996,10(1):32～39
22，Jehu U.Phase Ⅱ trial of double-consolidation following intensive induction treatmentfor improvement of survival in elderly patients with acute myeloid leukemia.LeukLymphoma,1994,12(5):435～440
33，Baudard M,Marie JP,Cadion M,et al.Acute myelogenous leukemia in theelderly:retrospective study of 235 consecutive patients.Br J Haematol,1994,86(1):82～91
44，MacCallum PK,Rohatiner AZ,Davis CL,et al.Mitoxantrone and cytosine arabinoside astreatment for acute myeloblastic leukemia in older patients.Ann Hemotol,1995,71(1):35～39
55，Ohno R,Tomonaga M,Kobayashi T,et al.Effect of granulocyte colony-stimulating factorafter intensive induction therapy in relapsed or refractory acute leukemia.N Engl JMed,1990,323(13):871～873
3Riley L C,Hann I M,Wheatley K. Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10).The MCR Childhood Leukaemia Working Party[J].British Journal of Haematology,1999,(02):436-444.
4Bowden G T,Roberts R,Albert D S. Comparative molecular Pharmacology in leukemia L 1210 cells of the anthracene anticancer drugs mitoxantrone and bisantrene[J].Cancer Research,1985.4915-4920.
5Liso V,Albano F,Pastore D. Bone marrow aspirate on the 14th day of induction treatment as a prognostic tool in de novo adult acute myeloid leukemia[J].Haematologica,2000,(12):1285-1290.
6Bienz M,Ludwig M,Leibundgut E O. Risk assessment in patients with acute myeloid leukemia and a normal ka ryotype[J].Clinical Cancer Research,2005,(04):1416-1424.
7张之南.血液学诊断及疗效标准[M]北京:科学出版社,1998214-248.
8Miller A B,Hoogstraten B,Staquet M. Reporting results of cancer treatment[J].Cancer,1981.207-214.
9Arlin Z,Case D C Jr,Moore J. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL).Lederle Cooperative Group[J].Leukemia:Official Journal of the Leukemia Society of America,Leukemia Research Fund,U.K,1990,(03):177-183.
10Arlin Z A,Silver R,Cassileth P. Phase Ⅰ-Ⅲ trial of mitoxantrone in acute leukemia[J].Cancer Treatment Reports,1985,(01):61-64.
